Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to -$7.9 million.

  • Healthstream's Cash from Financing Activities fell 76084.6% to -$7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.1 million, marking a year-over-year decrease of 15566.52%. This contributed to the annual value of -$4.5 million for FY2024, which is 6536.54% up from last year.
  • Latest data reveals that Healthstream reported Cash from Financing Activities of -$7.9 million as of Q3 2025, which was down 76084.6% from -$19.1 million recorded in Q2 2025.
  • In the past 5 years, Healthstream's Cash from Financing Activities ranged from a high of -$20000.0 in Q3 2022 and a low of -$20.2 million during Q1 2022
  • Moreover, its 5-year median value for Cash from Financing Activities was -$1.6 million (2023), whereas its average is -$4.2 million.
  • In the last 5 years, Healthstream's Cash from Financing Activities soared by 9917.82% in 2022 and then plummeted by 1750212.77% in 2023.
  • Healthstream's Cash from Financing Activities (Quarter) stood at -$5.7 million in 2021, then soared by 99.18% to -$47000.0 in 2022, then plummeted by 17502.13% to -$8.3 million in 2023, then soared by 87.51% to -$1.0 million in 2024, then tumbled by 668.34% to -$7.9 million in 2025.
  • Its last three reported values are -$7.9 million in Q3 2025, -$19.1 million for Q2 2025, and -$2.0 million during Q1 2025.